What Is Wegovy and Why Has It Become So Popular?
Wegovy (semaglutide 2.4 mg) is a once-weekly injectable prescription medication manufactured by Novo Nordisk that is FDA-approved for chronic weight management in adults with obesity or overweight with at least one weight-related comorbidity. Wegovy contains the same active ingredient as Ozempic (semaglutide) but at a higher dose specifically indicated for weight loss rather than diabetes management. In landmark clinical trials, Wegovy demonstrated average weight loss of approximately 15 percent of body weight, making it one of the most effective pharmaceutical weight-loss treatments ever approved.
Since its approval in 2021, Wegovy has generated enormous demand and has become one of the most talked-about prescription medications in the country. However, its high cost and variable insurance coverage have made access challenging for many patients. Understanding the pricing landscape, insurance coverage options, and available savings programs is essential for anyone considering or currently using Wegovy for weight management.
Wegovy Retail Pricing in 2026
The list price of Wegovy in 2026 is approximately 1,300 to 1,500 dollars per month for a single carton containing four pre-filled pens at the maintenance dose of 2.4 mg. Retail cash prices vary by pharmacy, with typical prices of approximately 1,350 to 1,450 dollars at CVS, 1,340 to 1,430 dollars at Walgreens, 1,300 to 1,400 dollars at Walmart, and 1,280 to 1,380 dollars at Costco. These prices represent the full retail cost without insurance and place Wegovy among the most expensive commonly prescribed medications in the United States.
Wegovy is prescribed as a dose escalation regimen that begins at 0.25 mg weekly and gradually increases over 16 to 20 weeks to the maintenance dose of 2.4 mg weekly. Each dose level requires a different pen, and the cost per month is similar across all dose levels. Patients typically reach the full maintenance dose after four to five months of treatment and continue at that dose indefinitely for ongoing weight management.
Insurance Coverage for Wegovy
Commercial Insurance
Insurance coverage for Wegovy is more variable and often more restrictive than for diabetes medications because weight-loss drugs have historically been excluded from many insurance formularies. However, coverage has been expanding steadily as the evidence for the health benefits of medically managed weight loss continues to grow. As of 2026, an estimated 40 to 50 percent of commercial insurance plans provide some coverage for Wegovy, up from approximately 25 percent in 2023.
Plans that cover Wegovy typically require prior authorization, which involves documenting a BMI of 30 or greater, or a BMI of 27 or greater with at least one weight-related comorbidity such as hypertension, type 2 diabetes, or dyslipidemia. Many plans also require documentation of previous weight-loss attempts through diet and exercise, and some require concurrent participation in a lifestyle modification program. When covered, Wegovy is usually placed on a specialty or non-preferred brand tier with copays ranging from 50 to 250 dollars per month or coinsurance of 25 to 50 percent.
Medicare Coverage
In a significant policy development, Medicare Part D began covering anti-obesity medications for qualifying beneficiaries under provisions of recent federal legislation. This change has expanded access to Wegovy for millions of Medicare beneficiaries with obesity. Coverage is subject to standard Part D formulary requirements, including prior authorization and the annual out-of-pocket cap of 2,000 dollars. Medicare Advantage plans may offer additional coverage options with varying cost structures.
Medicaid Coverage
Medicaid coverage for anti-obesity medications varies significantly by state. Some states have begun covering Wegovy under their Medicaid programs, while others continue to exclude weight-loss medications from coverage. States that provide coverage typically require prior authorization and may have specific clinical criteria that must be met. Check with your state Medicaid program for current coverage policies.
Novo Nordisk Savings Programs
Novo Nordisk offers the Wegovy Savings Card for commercially insured patients, which can reduce the monthly copay to as low as 0 to 25 dollars for eligible patients. The savings card covers the difference between your insurance copay and the reduced amount, up to a maximum benefit per fill and per year. This card is available to patients with commercial insurance that covers Wegovy and cannot be combined with government insurance programs.
For patients without insurance coverage, Novo Nordisk offers periodic savings offers that can significantly reduce the cash price of Wegovy for a limited period. The Novo Nordisk Patient Assistance Program may also provide Wegovy at no cost to qualifying patients with financial need. Eligibility requirements include household income thresholds and lack of prescription drug coverage.
Discount Card and Cash-Pay Options
Prescription discount cards provide modest savings on Wegovy compared to the full retail price. GoodRx, SingleCare, and RxSaver typically show discount prices of 1,100 to 1,350 dollars per month, representing savings of approximately 10 to 20 percent off retail. While these savings are meaningful, the resulting price is still prohibitive for most patients paying entirely out of pocket. For cash-pay patients, exploring all available savings programs and comparing prices at multiple pharmacies is essential to minimizing costs.
Alternatives to Wegovy
Other GLP-1 Weight-Loss Medications
Zepbound (tirzepatide) is a competing weight-loss medication manufactured by Eli Lilly that has shown even greater average weight loss in clinical trials, approximately 20 to 25 percent of body weight. Zepbound has a similar cost profile to Wegovy, and insurance coverage varies. Saxenda (liraglutide 3 mg) is an older daily injectable GLP-1 for weight management that may be available at a lower cost or covered by insurance plans that do not cover Wegovy. Discuss all available options with your doctor to find the best balance of efficacy, cost, and insurance coverage.
Off-Label Use of Ozempic
Some patients and providers have used Ozempic off-label for weight loss because it contains the same active ingredient as Wegovy and may be covered by insurance at a lower cost when prescribed for type 2 diabetes. However, using Ozempic off-label for weight loss raises ethical and coverage considerations, and the FDA-approved dose for diabetes is lower than the Wegovy weight-loss dose. Discuss the appropriateness and risks of off-label use with your healthcare provider.
Is Wegovy Worth the Cost?
The value proposition of Wegovy depends on individual circumstances including the severity of obesity, the presence of weight-related comorbidities, previous weight-loss attempts, and the out-of-pocket cost after insurance and savings programs. Clinical evidence supports significant health benefits from the degree of weight loss achieved with Wegovy, including reduced risk of cardiovascular events, improved blood sugar control, lower blood pressure, improved sleep apnea, reduced joint pain, and improved quality of life.
When evaluating cost, consider the long-term health costs of untreated obesity, which include higher rates of diabetes, heart disease, stroke, certain cancers, and joint problems, all of which carry significant medical expenses. For patients who achieve meaningful weight loss with Wegovy, the long-term cost savings from reduced medical expenses may offset the cost of the medication. However, it is important to note that weight regain is common after stopping GLP-1 medications, which means ongoing treatment may be necessary to maintain results.
Steps to Get Started with Wegovy
If you are considering Wegovy, start by scheduling an appointment with your doctor to discuss whether you are a candidate based on your BMI, health conditions, and medication history. Have your doctor office check your insurance coverage and initiate any required prior authorization. Ask about manufacturer savings programs and apply for the Wegovy Savings Card if you have commercial insurance. Compare pharmacy prices using discount card platforms. If cost remains a barrier, ask your doctor about alternative medications that may be more affordable while still providing meaningful weight-loss benefits.